CD28 and vasculitis: A study in patients with antineutrophil cytoplasmic antibody–associated vasculitis showed that treatment with valacyclovir reduced CMV reactivation and the proportion of CD28- CD4+ T cells.262 The reduction in CD28- CD4+ T cells was accompanied by improved responses to a pneumococcal vaccine.